Pyxis Oncology Inc — Quarterly Financial Statistics (NASDAQ:PYXS) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities 14.66 M19.29 M22.54 M17.26 M13.28 M 72.36 M Cash from investing activities 8 000-10.35 M15.82 M15.3 M11.47 M 32.25 M Cash from financing activities 1.66 M50 K-2 000-67 K-8 000 -27 K Free cash flow 14.66 M19.29 M22.54 M17.26 M13.28 M 72.36 M

뉴스

Pyxis Oncology, 토마스 시빅 임시 CEO 임명

Pyxis Oncology appoints Thomas Civik as interim CEO

Pyxis Oncology 목표 주가, H.C. Wainwright, 7달러로 상향

Pyxis Oncology stock price target raised to $7 by H.C. Wainwright

Analysts Sound Alarm On Pyxis Oncology's Tiny Trial - Pyxis Oncology (NASDAQ:PYXS)

Tesla To $444? Here Are 10 Top Analyst Forecasts For Friday - AGCO (NYSE:AGCO), Assurant (NYSE:AIZ)

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14%

Pyxis Oncology, RBC 목표가 하향 조정에 주가 하락

Pyxis Oncology stock falls as RBC cuts price target on complex trial data

Pyxis Oncology, Inc. (PYXS) Discusses Preliminary Phase 1 Data for MICVO in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Transcript

Pyxis Oncology, Inc. (PYXS) Discusses Preliminary Phase 1 Data for MICVO in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma - Slideshow (NASDAQ:PYXS) 2025-12-18

파이시스 온콜로지, 초기 암 치료제 데이터 발표 후 주가 급락